Background/Aims: Autoimmune hypophysitis (AH) is a rare inflammatory disease of the pituitary gland causing varying degrees of hypopituitarism and/or sellar compression. Cranial MRI remains the best noninvasive tool to diagnose AH, although a diagnosis of certainty requires pituitary biopsy. The objective of this study was to assess the utility of detecting pituitary antibodies for the diagnosis of AH. Methods: A 15-year-old female with Turner syndrome (TS), hypothyroidism, and ovarian failure presented acutely with hypocortisolism. Laboratory studies revealed secondary adrenal insufficiency. MRI showed a hypotrophic pituitary gland and loss of the posterior pituitary bright spot. To establish an autoimmune basis for the adrenal insufficiency, serum was analyzed by double indirect immunofluorescence for the presence of pituitary autoantibodies. Results: The patient's serum contained autoantibodies that recognized 36% of the adrenocorticotropic hormone-secreting cells, suggesting that these adenohypophyseal cells were targeted by autoimmunity. The serum contained antibodies that identified the majority of the gonadotropin-secreting cells (FSH 77%, LH 65%). No recognition of GH-, prolactin-, and TSH-secreting cells was found. Preabsorption experiments showed that antigenic targets of autoantibodies were not anterior pituitary hormones themselves. Conclusion: Demonstration of circulating pituitary antibodies expands the diagnostic options for AH. In this adolescent with TS, positive and cell-specific pituitary antibodies suggested that AH was the cause of her secondary adrenal insufficiency.

Keywords:
Pituitary gland, Adrenal insufficiency, Autoantibodies, Turner syndrome, Hypophysitis
1.
Leporati P, Landek-Salgado MA, Lupi I, Chiovato L, Caturegli P: IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab 2011;96:1971-1980.
2.
Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR: Autoimmune hypophysitis. Endocr Rev 2005;26:599-614.
3.
Gutenberg A, Landek-Salgado MA, Tzou SC, Lupi I, Geis A, Kimura H, Caturegli P: Autoimmune hypophysitis: expanding the differential diagnosis to CTLA-4 blockade. Expert Rev Endocrinol Metab 2009;4:681-698.
4.
Bertrand A, Kostine M, Barnetche T, Truchetet ME, Schaeverbeke T: Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis. BMC Med 2015;13:211.
5.
Wilson V, Mallipedhi A, Stephens JW, Redfern RM, Price DE: The causes of hypopituitarism in the absence of abnormal pituitary imaging. QJM 2014;107:21-24.
6.
Albarel F, Gaudy C, Castinetti F, Carre T, Morange I, Conte-Devolx B, Grob JJ, Brue T: Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma. Eur J Endocrinol 2015;172:195-204.
7.
Faje AT, Sullivan R, Lawrence D, Tritos NA, Fadden R, Klibanski A, Nachtigall L: Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma. J Clin Endocrinol Metab 2014;99:4078-4085.
8.
Min L, Hodi FS, Giobbie-Hurder A, Ott PA, Luke JJ, Donahue H, Davis M, Carroll RS, Kaiser UB: Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study. Clin Cancer Res 2015;21:749-755.
9.
Gellner V, Kurschel S, Scarpatetti M, Mokry M: Lymphocytic hypophysitis in the pediatric population. Childs Nerv Syst 2008;24:785-792.
10.
Howlett TA, Levy MJ, Robertson IJ: How reliably can autoimmune hypophysitis be diagnosed without pituitary biopsy. Clin Endocrinol (Oxf) 2010;73:18-21.
11.
Gutenberg A, Larsen J, Lupi I, Rohde V, Caturegli P: A radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively. AJNR Am J Neuroradiol 2009;30:1-8.
12.
Nakata Y, Sato N, Masumoto T, Mori H, Akai H, Nobusawa H, Adachi Y, Oba H, Ohtomo K: Parasellar T2 dark sign on MR imaging in patients with lymphocytic hypophysitis. AJNR Am J Neuroradiol 2010;31:1944-1950.
13.
Gao H, Gu YY, Qiu MC: Autoimmune hypophysitis may eventually become empty sella. Neuro Endocrinol Lett 2013;34:102-106.
14.
Karaca Z, Tanriverdi F, Unluhizarci K, Kelestimur F, Donmez H: Empty sella may be the final outcome in lymphocytic hypophysitis. Endocr Res 2009;34:10-17.
15.
Lupi I, Zhang J, Gutenberg A, Landek-Salgado M, Tzou SC, Mori S, Caturegli P: From pituitary expansion to empty sella: disease progression in a mouse model of autoimmune hypophysitis. Endocrinology 2011;152:4190-4198.
16.
De Bellis A, Bellastella G, Colella C, Bizzarro A, Bellastella A, Esposito K: Use of serum pituitary antibodies to improve the diagnosis of hypophysitis. Expert Rev Endocrinol Metabol 2014;9:465-476.
17.
Ricciuti A, De Remigis A, Landek-Salgado MA, De Vincentiis L, Guaraldi F, Lupi I, Iwama S, Wand GS, Salvatori R, Caturegli P: Detection of pituitary antibodies by immunofluorescence: approach and results in patients with pituitary diseases. J Clin Endocrinol Metab 2014;99:1758-1766.
18.
Bakalov VK, Gutin L, Cheng CM, Zhou J, Sheth P, Shah K, Arepalli S, Vanderhoof V, Nelson LM, Bondy CA: Autoimmune disorders in women with Turner syndrome and women with karyotypically normal primary ovarian insufficiency. J Autoimmun 2012;38:315-321.
19.
Lleo A, Moroni L, Caliari L, Invernizzi P: Autoimmunity and Turner's syndrome. Autoimmun Rev 2012;11:A538-A543.
20.
Germain EL, Plotnick LP: Age-related anti-thyroid antibodies and thyroid abnormalities in Turner syndrome. Acta Paediatr Scand 1986;75:750-755.
21.
Grossi A, Crino A, Luciano R, Lombardo A, Cappa M, Fierabracci A: Endocrine autoimmunity in Turner syndrome. Ital J Pediatr 2013;39:79.
22.
Bianchi I, Lleo A, Gershwin ME, Invernizzi P: The X chromosome and immune associated genes. J Autoimmun 2012;38:J187-J192.
23.
Bottazzo GF, McIntosh C, Stanford W, Preece M: Growth hormone cell antibodies and partial growth hormone deficiency in a girl with Turner's syndrome. Clin Endocrinol (Oxf) 1980;12:1-9.
24.
Gluck M, Attanasio A, Speer U, Butenandt O, Tietze HU, Scherbaum WA: Prevalence of autoantibodies to endocrine organs in girls with Ullrich-Turner syndrome aged 5-14 years. Horm Res 1992;38:114-119.
25.
Romijn HJ, van Uum JF, Breedijk I, Emmering J, Radu I, Pool CW: Double immunolabeling of neuropeptides in the human hypothalamus as analyzed by confocal laser scanning fluorescence microscopy. J Histochem Cytochem 1999;47:229-236.
26.
Jorgensen KT, Rostgaard K, Bache I, Biggar RJ, Nielsen NM, Tommerup N, Frisch M: Autoimmune diseases in women with Turner's syndrome. Arthritis Rheum 2010;62:658-666.
27.
Mortensen KH, Cleemann L, Hjerrild BE, Nexo E, Locht H, Jeppesen EM, Gravholt CH: Increased prevalence of autoimmunity in Turner syndrome - influence of age. Clin Exp Immunol 2009;156:205-210.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.